Genus comes in on track
Genus, the global animal genetics company, said its full year figures would be in line with expectations after a good performance over the last two months.
Genus, the global animal genetics company, said its full year figures would be in line with expectations after a good performance over the last two months.
The company said pricing had remained firm, with adjusted operating profit improving in line with expectations despite increasing investment in research and growing its management teams.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Going forward, the firm expects strong growth in emerging markets, particularly in China.
The group's businesses in North America also performed well due to cost controls and improved royalty income offsetting softness there.
Europe had performed broadly in line with the prior year, it added.
-
‘Lifetime ISA reform rumours won’t fix the flaw – Reeves must address the property price problem’Lifetime ISA reform was an exciting announcement in the Autumn Budget. But launching a new ISA product which fails to address the frozen property price cap would be disappointing, says Jessica Sheldon
-
Best places to live in England and Wales in 2026 – and how much they costCriteria like value for money, natural beauty, good schools, jobs and a high quality of life are key for those looking at areas to buy a house – but how much will it cost you to live in a high ranking town or city? We reveal the best places to live in England and Wales.
